News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Mehra Anand
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/12/2023 |
4
| Mehra Anand (Director) has filed a Form 4 on Merus N.V.|
Txns:
| Granted 14,414 options to buy
@ $23.29, valued at
$335.7k
|
|
| 06/05/2023 |
4
| Mehra Anand (Director) has filed a Form 4 on Aclaris Therapeutics, Inc.|
Txns:
| Granted 15,750 options to buy
@ $8.7, valued at
$137k
Granted 4,660 restricted stock units
@ $0
Exercised 4,507 restricted stock units
@ $0 |
|
| 06/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/02/2022 |
4
| Mehra Anand (Director) has filed a Form 4 on Merus N.V.|
Txns:
| Granted 16,604 options to buy
@ $18.56, valued at
$308.2k
|
|
| 06/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/08/2020 |
4
| Mehra Anand (Director) has filed a Form 4 on Aclaris Therapeutics, Inc.|
Txns:
| Granted 16,500 options to buy
@ $1.41, valued at
$23.3k
Exercised 7,333 restricted stock units
@ $0 |
|
| 03/04/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/02/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 12/17/2019 |
4
| Mehra Anand (Director) has filed a Form 4 on Spark Therapeutics, Inc.|
Txns:
| Unknown transaction of 40,203 shares
@ $114.5, valued at
$4.6M
Unknown transaction of 481,270 shares
@ $114.5, valued at
$55.1M
Disposed/sold 4,000 options to buy
@ $81.53, valued at
$326.1k
Disposed/sold 4,000 options to buy
@ $50.93, valued at
$203.7k
Disposed/sold 6,000 options to buy
@ $56.22, valued at
$337.3k
|
|
| 11/19/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/12/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/06/2019 |
3
| Sofinnova Venture Partners IX, L.P. (10% Owner) has filed a Form 3 on Galera Therapeutics, Inc. |
| 06/10/2019 |
4
| Mehra Anand (Director) has filed a Form 4 on Aclaris Therapeutics, Inc.|
Txns:
| Granted 7,333 restricted stock units
@ $0 |
|
| 06/03/2019 |
4
| Mehra Anand (Director) has filed a Form 4 on Spark Therapeutics, Inc.|
Txns:
| Exercised 1,500 restricted stock units
@ $0 |
|
| 05/15/2019 |
4
| Sofinnova Venture Partners IX, L.P. (10% Owner) has filed a Form 4 on NextCure, Inc.|
Txns:
| Converted 278,759 shares
@ $0
Converted 464,599 shares
@ $0
Converted 908,785 shares
@ $0
Converted 469,713 shares
@ $0
Bought 400,000 shares
@ $15, valued at
$6M
Converted 2,239,500 preferred shares
@ $0
Converted 3,732,500 preferred shares
@ $0
Converted 7,301,000 options to buy
@ $0
Converted 3,773,585 preferred shares
@ $0 |
|
| 05/08/2019 |
3
| Sofinnova Venture Partners IX, L.P. (10% Owner) has filed a Form 3 on NextCure, Inc. |
| 01/08/2019 |
4
| Mehra Anand (Director) has filed a Form 4 on Spark Therapeutics, Inc.|
Txns:
| Exercised 37,203 options to buy
@ $3.45, valued at
$128.4k
|
|
| 10/23/2018 |
4
| Mehra Anand (Director) has filed a Form 4 on Aclaris Therapeutics, Inc.|
Txns:
| Bought 372,093 shares
@ $10.75, valued at
$4M
|
|
| 10/02/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/25/2018 |
3
| Sofinnova Venture Partners IX, L.P. (10% Owner) has filed a Form 3 on Entasis Therapeutics Holdings Inc. |
| 09/20/2018 |
4
| Sofinnova Venture Partners VIII, L.P. (10% Owner) has filed a Form 4 on Principia Biopharma Inc.|
Txns:
| Converted 625,482 shares
@ $0
Converted 521,235 shares
@ $0
Converted 453,954 shares
@ $0
Converted 167,537 shares
@ $0
Bought 270,000 shares
@ $17, valued at
$4.6M
Converted 625,482 preferred shares
@ $0
Converted 521,235 preferred shares
@ $0
Converted 453,954 options to buy
@ $0
Converted 167,537 preferred shares
@ $0 |
|
| 09/13/2018 |
3
| Sofinnova Venture Partners VIII, L.P. (10% Owner) has filed a Form 3 on Principia Biopharma Inc. |
| 06/08/2018 |
4
| Mehra Anand (Director) has filed a Form 4 on Aclaris Therapeutics, Inc.|
Txns:
| Granted 8,000 options to buy
@ $18.35, valued at
$146.8k
|
|
| 06/01/2018 |
4
| Mehra Anand (Director) has filed a Form 4 on Spark Therapeutics, Inc.|
Txns:
| Granted 4,000 options to buy
@ $81.53, valued at
$326.1k
Granted 1,500 restricted stock units
@ $0
Exercised 1,500 restricted stock units
@ $0 |
|
| 05/30/2018 |
4
| Sofinnova Venture Partners IX, L.P. (10% Owner) has filed a Form 4 on Iterum Therapeutics plc|
Txns:
| Converted 721,408 shares
@ $0
Converted 275,446 shares
@ $0
Converted 229,660 shares
@ $0
Bought 500,000 shares
@ $13, valued at
$6.5M
Converted 721,408 options to buy
@ $0
Converted 275,446 options to buy
@ $0
Converted 229,660 options to buy
@ $0 |
|
| 05/24/2018 |
3
| Sofinnova Venture Partners IX, L.P. (10% Owner) has filed a Form 3 on Iterum Therapeutics plc |
| 07/26/2017 |
4
| Mehra Anand (Director) has filed a Form 4 on Spark Therapeutics, Inc.|
Txns:
| Sold 199,311 shares
@ $70.04, valued at
$14M
Sold 7,350 shares
@ $71.59, valued at
$526.2k
Sold 4,679 shares
@ $72.28, valued at
$338.2k
Sold 518 shares
@ $73.1, valued at
$37.9k
|
|
| 06/22/2017 |
4
| Mehra Anand (Director) has filed a Form 4 on Spark Therapeutics, Inc.|
Txns:
| Sold 1,020 shares
@ $65, valued at
$66.3k
Sold 5,282 shares
@ $65, valued at
$343.3k
|
|
| 06/16/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/06/2017 |
4
| Mehra Anand (Director) has filed a Form 4 on Spark Therapeutics, Inc. |
| 03/01/2017 |
4
| Mehra Anand (Director) has filed a Form 4 on Spark Therapeutics, Inc. |
|
|
|